Via WRAL, a look at the work of the Wake Forest Institute for Regenerative Medicine: "The Wake Forest Institute for Regenerative Medicine includes scientists and physicians in the fields of biomedical and chemical engineering, cell and molecular biology, biochemistry, physiology, materials science, nanotechnology, genomics, proteomics, drug delivery, surgery and medicine. ... we push forward in our efforts to develop more efficient ways to enhance cell growth and function in vitro and fabricate biomaterial scaffolds for tissue generation in three-dimensions. ... We have numerous ongoing and planned projects that represent the next phases of advancement toward the clinic as well as expansion into an increasing array of tissue types, ranging from organs such as kidneys, livers and heart valves, to tissues and cells for therapy, such as cartilage, bones and nerve cells. I would, however, recommend cautious optimism in this complex and nascent field of regenerative medicine. Our team, together with renowned scientists from other institutions, have been working on these or similar projects for almost two decades, and it could be years before commercial-scale production of engineered organs is viable."